Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss

Frisone, D; Charrier, M; Clement, S; Christinat, Y; Thouvenin, L; Homicsko, K; Michielin, O; Bodmer, A; Chappuis, PO; McKee, TA; Tsantoulis, P

Frisone, D (reprint author), Hop Univ Geneve, Dept Oncol, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.

CANCER BIOLOGY & THERAPY, 2020; 21 (3): 197

Abstract

Alterations of the Retinoblastoma (Rb) pathway are frequent in ovarian cancer, typically resulting from CDKN2A down-regulation, CCNE1 amplification, C......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索